Hepatitis B vaccine recombinant - Sinovac Biotech
Alternative Names: Recombinant Hepatitis B vaccine - Sinovac BiotechLatest Information Update: 28 Aug 2022
At a glance
- Originator Sinovac Biotech
- Class DNA vaccines; Hepatitis B vaccines; Synthetic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Hepatitis B
Most Recent Events
- 28 Aug 2022 No recent reports of development identified for phase-I development in Hepatitis-B(In adolescents, In children, In infants, In neonates, Prevention, In adults) in China (Parenteral, Injection)
- 25 Jul 2021 Sinovac Biotech completes a Phase-I clinical trial in Hepatitis B (Prevention, In children, In adolescents, In infants, In adults, In neonates) in China (Parenteral) (NCT04075201)
- 07 Jul 2019 Phase-I clinical trials in Hepatitis B (Prevention, In children, In adolescents, In infants, In adults, In neonates) in China (Parenteral) (NCT04075201)